Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease: A reappraisal of the role of S-cerevisiae in this setting

被引：8
|
作者：
Sendid, B. [1 ,2 ]
Jawhara, S. [1 ]
Sarter, H. [1 ]
Maboudou, P. [3 ]
Thierny, C. [3 ]
Gower-Rousseau, C. [1 ]
Colombel, J. F. [4 ]
Poulain, D. [1 ,2 ]
机构：
[1] Univ Lille, INSERM, CHU Lille, LIRIC,UMR995, Lille, France
[2] CHU Lille, Parasitol Mycol, Inst Microbiol Lille, Lille, France
[3] CHU Lille, Inst Biochim & Biol Mol, Lab Biochim, Lille, France
[4] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY 10029 USA
来源：
VIRULENCE | 2018年 / 9卷 / 01期
关键词：
Anti-Saccharomyces cerevisiae antibodies (ASCA); Crohn's disease; Inflammatory Bowel Diseases; pathogenesis; uric acid; yeasts; INFLAMMATORY-BOWEL-DISEASE; CANDIDA-ALBICANS; GLYCAN ANTIBODIES; MARKERS; MANNAN; TRANSMISSION; PREVALENCE; VIRULENCE; STRAINS; FUNGI;
D O I：
10.1080/21505594.2018.1496779
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
下载
收藏
页码：1224 / 1229
页数：6
相关论文
共 50 条
  • [21] Targeting Tissular Immune Response Improves Diagnostic Performance of Anti-Saccharomyces cerevisiae Antibodies (ASCA) in Crohn's Disease
    Bertin, Daniel
    Grimaud, Jean-Charles
    Lesavre, Nathalie
    Benelmouloud, Chahine
    Desjeux, Ariadne
    Garcia, Stephane
    Desplat-Jego, Sophie
    PLOS ONE, 2013, 8 (11):
  • [22] Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies:: a reassessment
    Aydin, S. Z.
    Atagunduz, P.
    Temel, M.
    Bicakcigil, M.
    Tasan, D.
    Direskeneli, H.
    RHEUMATOLOGY, 2008, 47 (02) : 142 - 144
  • [23] Anti-saccharomyces cerevisiae (ASCA) antibodies - A novel serologic marker for Beheet's disease (BD).
    Krause, I
    Monselise, Y
    Milo, G
    Weiberger, A
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S191 - S191
  • [24] Saccharomyces boulardii in Crohn's disease:: Effect on anti-Saccharomyces cerevisiae antibodies and intestinal permeability
    Joossens, S
    Suenaert, P
    Noman, M
    Vermeire, S
    Rutgeerts, P
    INFLAMMATORY BOWEL DISEASES, 2005, 11 (09) : 863 - 864
  • [25] Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease
    Van Kemseke, C
    Belaïche, J
    Steeman, C
    Louis, E
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2003, 66 (01) : 1 - 6
  • [26] Measurement of anti-Saccharomyces cerevisiae antibodies in human feces as a indicator of Crohn's disease
    Boone, JH
    Sandborn, WJ
    Pelanne, LMH
    Lyerly, DM
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S253 - S253
  • [27] Anti-Saccharomyces cerevisiae antibodies: A new subclinical marker for Crohn's disease.
    Colombel, JF
    Sendid, B
    Quinton, JF
    Jacquinot, PM
    Goulet, O
    Cortot, A
    Poulain, D
    GASTROENTEROLOGY, 1996, 110 (04) : A886 - A886
  • [28] Anti-Saccharomyces cerevisiae antibodies (ASCA) combined with anti neutrophil antibodies (ANCA) differentiate Crohn's disease from ulcerative colitis.
    Quinton, JF
    Sendid, B
    Reumaux, D
    Cortot, A
    Poulain, D
    Colombel, JF
    GASTROENTEROLOGY, 1997, 112 (04) : A1066 - A1066
  • [29] Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis
    Andretta, Marianne A.
    Vieira, Thais D.
    Nishiara, Renato
    Skare, Thelma L.
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (02) : 551 - 554
  • [30] Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases
    Muratori, P
    Muratori, L
    Guidi, M
    Maccariello, S
    Pappas, G
    Ferrari, R
    Gionchetti, P
    Campieri, M
    Bianchi, FB
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 132 (03): : 473 - 476
12345